Long-Term Use of Statins Lowering the Risk of Rehospitalization Caused by Ischemic Stroke Among Middle-Aged Hyperlipidemic Patients: A Population-Based Study
Conclusion: Statins were associated with long-term secondary prevention of reHospIS for hyperlipidemic patients. Rosuvastatin seemed to have the best protective effects. On the other hand, Bezafibrate appears to be beneficial for hyperlipidemic patients developing diabetes. Further research into the combination treatment of statin and nonstatin lipid-lowering medicines in hyperlipidemic patients developing diabetes is warranted.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cholesterol | Crestor | Databases & Libraries | Diabetes | Drugs & Pharmacology | Endocrinology | Gemfibrozil | Health Insurance | Heart | Heart Failure | Insurance | Ischemic Stroke | Lovastatin | Rosuvastatin | Statin Therapy | Stroke | Study | Taiwan Health